Novel peptidomimetics of the antifungal cyclic peptide rhodopeptin: Design of mimetics utilizing scaffolding methodology

Organic Letters

Volumn 3, Issue 22, 2001, Pages 3447-3450

  Nakayama, Kiyoshi ^a   Kawato, Haruko C ^a   Inagaki, Hiroaki ^a   Ohta, Toshiharu ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYCLOPEPTIDE; OLIGOPEPTIDE; RHODOPEPTIN;

ARTICLE; CHEMICAL STRUCTURE; DRUG DESIGN; MOLECULAR MIMICRY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTIFUNGAL AGENTS; DRUG DESIGN; MODELS, MOLECULAR; MOLECULAR MIMICRY; OLIGOPEPTIDES; PEPTIDES, CYCLIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035512704     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0163934     Document Type: Article

References (20)

1. (a) Belanger, P. C.; Dufresne, C. Can. J. Chem. 1986, 64, 1514.
2. (b) Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Salvino, J.; Leahy, E. M.; Sprengeler, P. A.; Furst, G.; Smith, A. B., III; Strader, C. D.; Cascieri, M. A.; Candelore, M. R.; Donaldson, C.; Vale, W.; Maechler, L. J. Am. Chem. Soc. 1992, 114, 9217.
3. (c) Hirschmann, R.; Nicolaou, K. C.; Pietranico, S.; Leahy, E. M.; Salvino, J.; Arison, B.; Cichy, M. A.; Spoors, P. G.; Shakespeare, W. C.; Sprengeler, P. A.; Hamley, P.; Smith, A. B., III; Reisine, T.; Raynor, K.; Maechler, L.; Donaldson, C.; Vale, W.; Freidinger, R. M.; Cascieri, M. A.; Strader, C. D. J. Am. Chem. Soc. 1993, 115, 12550.
4. (d) Hirschmann, R.; Hynes, J., Jr.; Cichy, M. A.; van Rijn, R. D.; Sprengeler, P. A.; Spoors, P. G.; Shakespeare, W. C.; Pietranico, S.; Barbosa, J.; Liu, J.; Yao, W.; Rohrer, S.; Smith, A. B., III. J. Med. Chem. 1998, 41, 1382.
5. (e) Olson, G. L.; Cheung, H.-C.; Chiang, E.; Madison, V. S.; Sepinwall, J.; Vincent, G. P.; Winokur, A.; Gary, K. A. J. Med. Chem. 1995, 38, 2866.
6. (a) Chiba, H.; Agematu, H.; Kaneto, R.; Terasawa, T.; Sakai, K.; Dobashi, K.; Yoshioka, T. J. Antibiot. 1999, 52, 695.
7. (b) Chiba, H.; Agematu, H.; Dobashi, K.; Yoshioka, T. J. Antibiotics 1999, 52, 700.
8. (c) Chiba, H.; Agematu, H.; Sakai, K.; Dobashi, K.; Yoshioka, T. J. Antibiot. 1999, 52, 710.
9. (d) Kawato, H. C.; Nakayama, K.; Inagaki, H.; Nakajima, R.; Kitamura, A.; Someya, K.; Ohta, T. Org. Lett. 2000, 2, 973.
10. (e) Nakayama, K.; Kawato, H. C.; Inagaki, H.; Nakajima, R.; Kitamura, A.; Someya, K.; Ohta, T. Org. Lett. 2000, 2, 977.
11. (a) De Lucca, A. J.; Walsh, T. J. Antimicrob. Agents Chemother. 1999, 43, 1.
12. (b) Barrett, J. F.; Klanbert, D. H. Ann. Rep. Med. Chem. 1992, 27, 149.
13. (c) Barrett, J. F.; Hey, R. J.; Peterson, P. K. New strategies in Fungal Disease; Churchill Livingstone: Edinburgh, 1992.
14. (d) Yamaguchi, H.; Kobayashi, G. S.; Takahashi, H. Recent Progress in Antifungal Chemotherapy; Marcell Dekker Inc.: New York, 1991.
15. (e) Balkovec, J. M. Exp. Opin. Invest. Drugs. 1994, 3, 65.
16. 1H NMR studies revealed intramolecular hydrogen bonding.
17. Molecular dynamics calculation with the X-PLOR program on the basis of restraints derived from NMR studies.
18. Conformational search using random sampling.
19. Molecular modeling (molecular similarity) by QUANTA97.
20. Nakayama, K.; Inagaki, H.; Ohta, T.; Kawato, H. C. Org. Lett. 2001, 3, 3451.